脑胶质瘤中西医结合临床诊疗专家共识(上海)

Expert consensus on integrated traditional Chinese and western medicine clinical diagnosis and treatment of brain glioma(Shanghai)

脑胶质瘤是一种起源于脑胶质细胞的颅内恶性肿瘤,其常规治疗方案为最大安全范围内的手术切除,术后放疗联合替莫唑胺并辅助替莫唑胺化疗,亦可辅助电场治疗,但临床治疗效果仍不理想。为充分发挥中医药在脑胶质瘤治疗中的作用、延长患者的生存期,上海市中西医结合学会神经外科专业委员会组织相关专家,通过查阅文献及参考名中医临床经验,就脑胶质瘤的西医诊断与分类、中医辨证论治、西医治疗等达成专家共识,以期为脑胶质瘤的临床诊疗提供依据。

Brain glioma is an intracranial malignant tumor originating from glial cells. The conventional therapeutic regimen is surgical resection within the maximum safe range, postoperative radiotherapy combined with temozolomide and adjuvant temozolomide for chemotherapy, or adjuvant electric field therapy. However, the clinical effect is still not ideal. In order to fully play the role of traditional Chinese medicine in the treatment of brain glioma and prolong the survival period of patients, Neurosurgery Professional Committee of Shanghai Association of Chinese Integrative Medicine organized relevant domestic experts to reach an expert consensus on the diagnosis and classification of western medicine, differentiation and treatment of traditional Chinese medicine, and western medical treatment of brain glioma by consulting relevant literatures and referring to the clinical experiences of famous doctors of traditional Chinese medicine.The aim is to provide a reference for the clinical diagnosis and treatment of brain glioma.